Literature DB >> 11003607

Modeling ischemia in vitro: selective depletion of adenine and guanine nucleotide pools.

P C Dagher1.   

Abstract

Intracellular ATP depletion is a hallmark event in ischemic injury. It has been extensively characterized in models of chemical anoxia in vitro. In contrast, the fate of GTP during ischemia remains unknown. We used LLC-PK proximal tubular cells to measure GTP and ATP changes during anoxia. In 45 min, antimycin A decreased ATP and GTP to 8% and 2% of controls, respectively. Ischemia in vivo resulted in comparable reductions in GTP and ATP. After 2 h of recovery, GTP levels in LLC-PK cells increased to 65% while ATP increased to 29%. We also investigated steady-state models of selective ATP or GTP depletion. Combinations of antimycin A and mycophenolic acid selectively reduced GTP to 51% or 25% of control. Similarly, alanosine selectively reduced ATP to 61% or 26% of control. Selective GTP depletion resulted in significant apoptosis. Selective ATP depletion caused mostly necrosis. These models of ATP or GTP depletion can prove useful in dissecting the relative contribution of the two nucleotides to the ischemic phenotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11003607     DOI: 10.1152/ajpcell.2000.279.4.C1270

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  16 in total

1.  Guanine nucleotides and acute renal failure.

Authors:  J M Weinberg; M A Venkatachalam
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

2.  Expression and distribution of HuR during ATP depletion and recovery in proximal tubule cells.

Authors:  Selvi C Jeyaraj; Duaa Dakhlallah; Stephanie R Hill; Beth S Lee
Journal:  Am J Physiol Renal Physiol       Date:  2006-06-20

3.  Alterations in membrane transport function and cell viability induced by ATP depletion in primary cultured rabbit renal proximal tubular cells.

Authors:  Sung Ju Lee; Chae Hwa Kwon; Yong Keun Kim
Journal:  Korean J Physiol Pharmacol       Date:  2009-02-28       Impact factor: 2.016

4.  Extracellular vesicles released from mesenchymal stromal cells modulate miRNA in renal tubular cells and inhibit ATP depletion injury.

Authors:  Rafael S Lindoso; Federica Collino; Stefania Bruno; Dayana S Araujo; Julliana F Sant'Anna; Ciro Tetta; Paolo Provero; Peter J Quesenberry; Adalberto Vieyra; Marcelo Einicker-Lamas; Giovanni Camussi
Journal:  Stem Cells Dev       Date:  2014-05-20       Impact factor: 3.272

5.  Guanosine supplementation reduces apoptosis and protects renal function in the setting of ischemic injury.

Authors:  K J Kelly; Z Plotkin; P C Dagher
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 6.  Pathogenesis of acute kidney injury: foundation for clinical practice.

Authors:  Gilbert R Kinsey; Mark D Okusa
Journal:  Am J Kidney Dis       Date:  2011-05-06       Impact factor: 8.860

7.  Differential patterns of peroxynitrite mediated apoptosis in proximal tubular epithelial cells following ATP depletion recovery.

Authors:  Vani Nilakantan; Huanling Liang; Cheryl J Maenpaa; Christopher P Johnson
Journal:  Apoptosis       Date:  2008-05       Impact factor: 4.677

8.  The metabolic inhibitor antimycin A can disrupt cell-to-cell communication by an ATP- and Ca(2+)-independent mechanism.

Authors:  Isabelle Plaisance; Fabien Duthe; Denis Sarrouilhe; Jean-Claude Hervé
Journal:  Pflugers Arch       Date:  2003-09-19       Impact factor: 3.657

9.  siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury.

Authors:  Bruce A Molitoris; Pierre C Dagher; Ruben M Sandoval; Silvia B Campos; Hagit Ashush; Eduard Fridman; Anat Brafman; Alexander Faerman; Simon J Atkinson; James D Thompson; Hagar Kalinski; Rami Skaliter; Shai Erlich; Elena Feinstein
Journal:  J Am Soc Nephrol       Date:  2009-05-21       Impact factor: 10.121

10.  Primary mouse renal tubular epithelial cells have variable injury tolerance to ischemic and chemical mediators of oxidative stress.

Authors:  Anne C Breggia; Jonathan Himmelfarb
Journal:  Oxid Med Cell Longev       Date:  2008 Oct-Dec       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.